Production (Stage)
FibroGen, Inc.
FGEN
$0.2639
-$0.0446-14.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.01M | -47.58M | -121.79M | -168.32M | -240.46M |
| Total Depreciation and Amortization | 2.20M | 2.69M | 4.22M | 5.85M | 7.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.87M | 24.35M | 34.74M | 32.95M | 67.70M |
| Change in Net Operating Assets | -89.06M | -117.46M | -43.02M | -72.50M | -107.74M |
| Cash from Operations | -75.99M | -138.00M | -125.85M | -202.02M | -272.72M |
| Capital Expenditure | -253.00K | -266.00K | -376.00K | -978.00K | -1.96M |
| Sale of Property, Plant, and Equipment | 1.05M | 1.05M | 840.00K | 3.00K | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 656.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.91M | 125.21M | 134.05M | 188.95M | 102.75M |
| Cash from Investing | 74.70M | 125.99M | 134.51M | 187.98M | 101.45M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 74.08M |
| Total Debt Repaid | -33.00K | -40.00K | -90.00K | -96.00K | -324.00K |
| Issuance of Common Stock | 139.00K | 139.00K | 161.00K | 161.00K | 20.48M |
| Repurchase of Common Stock | -238.00K | -354.00K | -340.00K | -229.00K | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -- | 0.00 | 0.00 | -2.75M |
| Cash from Financing | -178.00K | -255.00K | -506.00K | -401.00K | 91.10M |
| Foreign Exchange rate Adjustments | 1.94M | 751.00K | 1.94M | 2.57M | -2.65M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 466.00K | -11.51M | 10.09M | -11.87M | -82.82M |